Literature DB >> 16242143

The spectrum of cardiovascular anomalies in CHF1/Hey2 deficient mice reveals roles in endocardial cushion, myocardial and vascular maturation.

Yasuhiko Sakata1, Nobutaka Koibuchi, Fan Xiang, Joey M Youngblood, Caramai N Kamei, Michael T Chin.   

Abstract

CHF1/Hey2 null mice generated in different laboratories have discrepant cardiovascular phenotypes. To determine the effect of genetic background on phenotype, we backcrossed our knockout strain more than eight generations to the inbred strains BALB/c and C57BL/6. Knockout mice on these backgrounds showed disparate phenotypes. Mice on both backgrounds demonstrated ventricular septal defects (VSDs), tricuspid stenosis and mitral valve thickening, but at varying frequencies, suggesting a general defect in endocardial cushion remodeling. Additional defects seen exclusively on the C57BL/6 background included biventricular wall thinning and left ventricular enlargement, implying a more severe myocardial defect than previously observed. In addition, aortas and pulmonary arteries from these null mice had thinner walls. Intercrossing of the CHF1/Hey2 null mice on a C57BL/6 background with a C57BL/6 MLC2v-CHF1/Hey2 transgenic line overexpressing CHF1/Hey2 in the atrial and ventricular myocardium also rescued the VSD and myocardial phenotypes, but did not affect vascular wall thickness. Our results indicate that CHF1/Hey2 provides an important myocardial signal to the endocardial cushion for proper septation and valve formation and also plays an important role in maturation of the myocardium and vasculature.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16242143     DOI: 10.1016/j.yjmcc.2005.09.006

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  28 in total

1.  Myocardial deletion of transcription factor CHF1/Hey2 results in altered myocyte action potential and mild conduction system expansion but does not alter conduction system function or promote spontaneous arrhythmias.

Authors:  Matthew E Hartman; Yonggang Liu; Wei-Zhong Zhu; Wei-Ming Chien; Chad S Weldy; Glenn I Fishman; Michael A Laflamme; Michael T Chin
Journal:  FASEB J       Date:  2014-03-31       Impact factor: 5.191

2.  Duplication of HEY2 in cardiac and neurologic development.

Authors:  Valerie K Jordan; Jill A Rosenfeld; Seema R Lalani; Daryl A Scott
Journal:  Am J Med Genet A       Date:  2015-04-01       Impact factor: 2.802

3.  Artery/vein specification is governed by opposing phosphatidylinositol-3 kinase and MAP kinase/ERK signaling.

Authors:  Charles C Hong; Quinn P Peterson; Ji-Young Hong; Randall T Peterson
Journal:  Curr Biol       Date:  2006-07-11       Impact factor: 10.834

4.  Complex trait analysis of ventricular septal defects caused by Nkx2-5 mutation.

Authors:  Julia B Winston; Claire E Schulkey; Iuan-Bor D Chen; Suk D Regmi; Maria Efimova; Jonathan M Erlich; Courtney A Green; Ashley Aluko; Patrick Y Jay
Journal:  Circ Cardiovasc Genet       Date:  2012-04-24

Review 5.  Hey bHLH factors in cardiovascular development.

Authors:  Cornelia Wiese; Julia Heisig; Manfred Gessler
Journal:  Pediatr Cardiol       Date:  2009-12-24       Impact factor: 1.655

6.  The bHLH transcription factor CHF1/Hey2 regulates susceptibility to apoptosis and heart failure after pressure overload.

Authors:  Yonggang Liu; Man Yu; Ling Wu; Michael T Chin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-09       Impact factor: 4.733

7.  Heterogeneity of genetic modifiers ensures normal cardiac development.

Authors:  Julia B Winston; Jonathan M Erlich; Courtney A Green; Ashley Aluko; Kristine A Kaiser; Mai Takematsu; Robert S Barlow; Ashish O Sureka; Martin J LaPage; Luc L Janss; Patrick Y Jay
Journal:  Circulation       Date:  2010-03-08       Impact factor: 29.690

8.  CHF1/Hey2 promotes physiological hypertrophy in response to pressure overload through selective repression and activation of specific transcriptional pathways.

Authors:  Man Yu; Yonggang Liu; Fan Xiang; Yuxin Li; Darragh Cullen; Ronglih Liao; Richard P Beyer; Theodor K Bammler; Michael T Chin
Journal:  OMICS       Date:  2009-12

9.  Sodium valproate-induced congenital cardiac abnormalities in mice are associated with the inhibition of histone deacetylase.

Authors:  Gang Wu; Changlong Nan; Johnathon C Rollo; Xupei Huang; Jie Tian
Journal:  J Biomed Sci       Date:  2010-03-10       Impact factor: 8.410

10.  Transcription Factor CHF1/Hey2 Regulates Specific Pathways in Serum Stimulated Primary Cardiac Myocytes: Implications for Cardiac Hypertrophy.

Authors:  Man Yu; Fan Xiang; Richard P Beyer; Federico M Farin; Theo K Bammler; Michael T Chin
Journal:  Curr Genomics       Date:  2010-06       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.